NASDAQ : TCRX
TScan Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.1949 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
TScan Therapeutics, Inc. (TCRX) reported revenue of 7.11M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 7.11M | 10.32M | 2.82M | 21.05M | 13.54M | 10.14M |
| Cost of Revenue | 95.43M | 112.55M | 107.35M | 88.15M | 59.82M | 44.95M |
| Gross Profit | -88.32M | -102.22M | -104.53M | -67.10M | -46.28M | -34.81M |
| Selling, General & Admin | 30.22M | 31.59M | 30.29M | 26.35M | 20.35M | 13.83M |
| Operating Expenses | 30.22M | 31.59M | 30.29M | 26.35M | 20.35M | 13.83M |
| Operating Income | -118.54M | -133.81M | -134.82M | -93.46M | -66.64M | -48.64M |
| Interest Expense | -2.79M | -2.77M | -3.65M | -3.76M | -1.18M | |
| Interest & Investment Income | 5.62M | 8.82M | 12.06M | 8.00M | 1.59M | 16.00K |
| EBT Excluding Unusual Items | -115.71M | -127.77M | -126.41M | -89.22M | -66.22M | -48.62M |
| Merger & Restructuring Charges | -2.00M | -2.00M | ||||
| Other Unusual Items | -1.09M | |||||
| Pretax Income | -117.71M | -129.77M | -127.50M | -89.22M | -66.22M | -48.62M |
| Net Income | -117.71M | -129.77M | -127.50M | -89.22M | -66.22M | -48.62M |
| Net Income to Common | -117.71M | -129.77M | -127.50M | -89.22M | -66.22M | -48.62M |
| Shares Outstanding (Basic) | 67.78M | 56.90M | 56.59M | 47.83M | 24.05M | 11.66M |
| Shares Outstanding (Diluted) | 67.78M | 56.90M | 56.59M | 47.83M | 24.05M | 11.66M |
| EPS (Basic) | -1.74 | -2.28 | -2.25 | -1.87 | -2.75 | -4.17 |
| EPS (Diluted) | -1.74 | -2.28 | -2.25 | -1.87 | -2.75 | -4.17 |
| Free Cash Flow | -118.44M | -139.73M | -114.65M | -64.50M | -70.73M | -58.62M |
| Free Cash Flow Per Share | -1.75 | -2.46 | -2.03 | -1.35 | -2.94 | -5.03 |
| Operating Margin | -1,667.02% | -1,296.01% | -4,787.68% | -444.00% | -492.32% | -479.65% |
| Profit Margin | -1,655.35% | -1,256.81% | -4,527.66% | -423.86% | -489.26% | -479.49% |
| Free Cash Flow Margin | -1,665.57% | -1,353.28% | -4,071.27% | -306.45% | -522.56% | -578.03% |
| EBITDA | -115.66M | -130.95M | -130.71M | -88.10M | -61.50M | -45.31M |
| D&A For EBITDA | 2.88M | 2.87M | 4.11M | 5.36M | 5.14M | 3.33M |
| EBIT | -118.54M | -133.81M | -134.82M | -93.46M | -66.64M | -48.64M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 100.16M | 152.41M | 178.69M | 133.36M | 120.03M | 161.41M |
| Short-Term Investments | 111.42M | 58.69M | ||||
| Cash & Short-Term Investments | 100.16M | 152.41M | 290.11M | 192.04M | 120.03M | 161.41M |
| Prepaid Expenses | 4.25M | 4.80M | 2.61M | 2.19M | 4.10M | 4.25M |
| Total Current Assets | 104.40M | 157.21M | 292.72M | 194.24M | 124.13M | 165.65M |
| Property, Plant & Equipment | 61.97M | 66.45M | 71.60M | 71.23M | 69.20M | 17.26M |
| Other Long-Term Assets | 5.08M | 5.13M | 6.80M | 6.68M | 5.76M | 5.20M |
| Total Assets | 171.45M | 228.79M | 371.12M | 272.15M | 199.09M | 188.11M |
| Accounts Payable | 3.12M | 1.24M | 4.28M | 2.37M | 2.91M | 1.76M |
| Accrued Expenses | 7.64M | 7.47M | 15.33M | 10.29M | 6.41M | 5.50M |
| Current Portion of Long-Term Debt | 11.71M | 3.35M | ||||
| Current Portion of Leases | 7.72M | 7.17M | 4.57M | 3.25M | 3.68M | 1.65M |
| Current Unearned Revenue | 586.00K | 2.62M | 11.70M | 10.14M | 3.87M | 11.41M |
| Other Current Liabilities | 190.00K | 196.00K | 76.00K | 425.00K | 431.00K | 1.01M |
| Total Current Liabilities | 30.96M | 18.70M | 35.96M | 29.82M | 17.30M | 21.34M |
| Long-Term Debt | 21.07M | 32.53M | 32.07M | 26.70M | 29.29M | |
| Long-Term Leases | 50.40M | 54.44M | 60.74M | 59.14M | 53.01M | 4.39M |
| Long-Term Unearned Revenue | 1.25M | 5.62M | 1.50M | |||
| Other Long-Term Liabilities | 135.00K | 49.00K | 97.00K | |||
| Total Liabilities | 102.43M | 105.67M | 130.15M | 121.28M | 99.66M | 27.33M |
| Common Stock | 8.00K | 6.00K | 6.00K | 5.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 632.90M | 627.98M | 616.01M | 398.46M | 257.81M | 252.93M |
| Retained Earnings | -563.89M | -504.86M | -375.10M | -247.60M | -158.38M | -92.16M |
| Comprehensive Income & Other | 51.00K | |||||
| Total Common Equity | 69.02M | 123.12M | 240.97M | 150.87M | 99.43M | 160.78M |
| Shareholders' Equity | 69.02M | 123.12M | 240.97M | 150.87M | 99.43M | 160.78M |
| Total Liabilities & Equity | 171.45M | 228.79M | 371.12M | 272.15M | 199.09M | 188.11M |
| Total Debt | 90.89M | 94.14M | 97.38M | 92.43M | 85.98M | 6.04M |
| Net Cash (Debt) | 9.26M | 58.27M | 192.73M | 99.61M | 34.04M | 155.36M |
| Net Cash Per Share | 0.14 | 1.02 | 3.41 | 2.08 | 1.42 | 13.32 |
| Filing Date Shares Outstanding | 67.78M | 56.90M | 56.59M | 47.88M | 24.23M | 23.86M |
| Total Common Shares Outstanding | 67.78M | 56.90M | 56.59M | 47.83M | 24.23M | 23.91M |
| Working Capital | 73.44M | 138.51M | 256.77M | 164.42M | 106.82M | 144.31M |
| Book Value Per Share | 1.02 | 2.16 | 4.26 | 3.15 | 4.10 | 6.72 |
| Tangible Book Value | 69.02M | 123.12M | 240.97M | 150.87M | 99.43M | 160.78M |
| Tangible Book Value Per Share | 1.02 | 2.16 | 4.26 | 3.15 | 4.10 | 6.72 |
| Machinery | 24.77M | 22.59M | 18.63M | 16.87M | 12.15M | |
| Construction In Progress | 118.00K | 100.00K | 548.00K | 5.00K | 1.26M | |
| Leasehold Improvements | 5.39M | 3.26M | 3.16M | 3.45M | 3.43M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -117.71M | -129.77M | -127.50M | -89.22M | -66.22M | -48.62M |
| Depreciation & Amortization | 2.88M | 2.87M | 4.11M | 5.36M | 5.14M | 3.33M |
| Loss (Gain) From Sale of Assets | 99.00K | |||||
| Loss (Gain) From Sale of Investments | -346.00K | -2.41M | -3.90M | -1.07M | ||
| Stock-Based Compensation | 9.84M | 11.71M | 9.55M | 5.21M | 4.55M | 2.52M |
| Other Operating Activities | 483.00K | 462.00K | 1.86M | 757.00K | 260.00K | |
| Change in Accounts Payable | -1.25M | -3.01M | 1.99M | -52.00K | 528.00K | 10.00K |
| Change in Unearned Revenue | -7.11M | -10.32M | -2.81M | 11.88M | -9.03M | -6.54M |
| Change in Other Net Operating Assets | -3.17M | -4.84M | 5.88M | 5.77M | -1.73M | 630.00K |
| Operating Cash Flow | -116.28M | -135.32M | -110.82M | -61.36M | -66.50M | -48.68M |
| Capital Expenditures | -2.16M | -4.41M | -3.83M | -3.15M | -4.22M | -9.94M |
| Investment in Securities | 49.00M | 113.78M | -48.79M | -57.61M | ||
| Investing Cash Flow | 46.87M | 109.37M | -52.61M | -60.76M | -4.22M | -9.94M |
| Long-Term Debt Issued | 32.46M | 29.35M | ||||
| Long-Term Debt Repaid | -17.14M | |||||
| Net Debt Issued (Repaid) | 15.31M | 29.35M | ||||
| Issuance of Common Stock | 172.00K | 264.00K | 35.18M | 43.12M | 326.00K | 89.94M |
| Other Financing Activities | -600.00K | 158.27M | 92.32M | -324.00K | ||
| Financing Cash Flow | 172.00K | -336.00K | 208.76M | 135.44M | 29.36M | 189.67M |
| Net Cash Flow | -69.24M | -26.28M | 45.33M | 13.33M | -41.37M | 131.05M |
| Free Cash Flow | -118.44M | -139.73M | -114.65M | -64.50M | -70.73M | -58.62M |
| Free Cash Flow Margin | -1,665.57% | -1,353.28% | -4,071.27% | -306.45% | -522.56% | -578.03% |
| Free Cash Flow Per Share | -1.75 | -2.46 | -2.03 | -1.35 | -2.94 | -5.03 |
| Levered Free Cash Flow | -79.92M | -97.25M | -68.97M | -41.83M | -42.84M | -33.43M |
| Unlevered Free Cash Flow | -78.18M | -95.52M | -66.69M | -39.48M | -42.10M | -33.43M |
| Cash Interest Paid | 2.31M | 2.31M | 2.88M | 3.00M | 660.00K | |
| Change in Working Capital | -11.53M | -18.18M | 5.05M | 17.61M | -10.23M | -5.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 11.83M | 56.75M | 171.78M | 278.82M | 37.32M | 106.93M |
| Enterprise Value | 2.56M | -32.08M | -8.99M | 150.38M | -66.08M | -68.98M |
| Last Close Price | 0.17 | 1.00 | 3.04 | 5.83 | 1.55 | 4.50 |
| PS Ratio | 1.66 | 5.50 | 61.00 | 13.25 | 2.76 | 10.54 |
| PB Ratio | 0.17 | 0.46 | 0.71 | 1.85 | 0.38 | 0.67 |
| P/TBV Ratio | 0.17 | 0.46 | 0.71 | 1.85 | 0.38 | 0.67 |
| EV/Sales Ratio | 0.36 | 7.14 | ||||
| Debt / Equity Ratio | 1.32 | 0.77 | 0.40 | 0.61 | 0.86 | 0.04 |
| Net Debt / Equity Ratio | -0.13 | -0.47 | -0.80 | -0.66 | -0.34 | -0.97 |
| Net Debt / EBITDA Ratio | 0.08 | 0.45 | 1.47 | 1.13 | 0.55 | 3.43 |
| Net Debt / FCF Ratio | 0.08 | 0.42 | 1.68 | 1.54 | 0.48 | 2.65 |
| Asset Turnover | 0.03 | 0.03 | 0.01 | 0.09 | 0.07 | 0.09 |
| Quick Ratio | 3.23 | 8.15 | 8.07 | 6.44 | 6.94 | 7.56 |
| Current Ratio | 3.37 | 8.41 | 8.14 | 6.51 | 7.17 | 7.76 |
| Return on Equity (ROE) | -95.80% | -71.28% | -65.08% | -71.29% | -50.90% | -54.64% |
| Return on Assets (ROA) | -31.53% | -27.88% | -26.20% | -24.79% | -21.51% | -25.56% |
| Return on Capital Employed (ROCE) | -84.40% | -63.70% | -40.20% | -38.60% | -36.70% | -29.20% |
| Earnings Yield | -995.24% | -228.67% | -74.22% | -32.00% | -177.43% | -45.48% |
| FCF Yield | -1,001.39% | -246.22% | -66.74% | -23.14% | -189.50% | -54.82% |
| Buyback Yield / Dilution | -19.44% | -0.55% | -18.32% | -98.89% | -106.20% | -1,173.20% |